Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995 to 1997

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 4, 1998, Pages 358-364

  Spira, Rosemary ^a,b   Marimoutou, Catherine ^a,b   Binquet, Christine ^a   Lacoste, Denis ^b   Dabis, François ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Death; Disease progression; Health care; HIV Antiretroviral therapy

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG USE; FEMALE; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032145559     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199808010-00007     Document Type: Article

References (19)

1. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996;348:283-91.
2. Hammer SM, Katzenstein DA, Hughes MD, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-90.
3. Staszewski S, Hill AM, Bartlett J, et al. Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials. AIDS 1997;11: 477-83.
4. Gulick R, Mellors J, Havlir D, et al. Potent and sustained antiretroviral activity of indinavir in combination with zidovudine and lamivudine [abstract LB7]. Program and Abstracts of the Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 28-February 1, 1996.
5. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
6. Dormont J. Stratégies d'utilisation des antirétroviraux dans l'infection par le VIH. Rapport au Ministère du Travail et des Affaires Sociales, Secrétariat d'Etat à la Santé et à la Sécurité Sociale. Paris: Flammarion Médecine-Sciences, 1997:34.
7. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the international AIDS society - USA panel. JAMA 1997;277: 1962-9.
8. British HIV Association Guidelines Coordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997;349:1086-92.
9. Dabis F, Chene G, Salamon R, et al. Hospital-based surveillance of HIV infection: Bordeaux, France 1983-1990 [letter]. AIDS 1991; 5:774-5.
10. Marimoutou C, Chene G, Dabis F, et al. Human immunodeficiency virus and AIDS hospital-based information system in Aquitaine, South-western France, 1985-1995 [in French]. Presse Med 1997; 26:703-10.
11. Centers for Disease Control. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Morbid Mortal Weekly Rep 1992;41:1-20.
12. Lacoste D, Marimoutou C, Dabis F, et al. Decreasing incidence of HIV infection among intravenous drug users: Aquitaine (South-West France), 1985-1993 [in French]. Presse Med 1996;25:1018-22.
13. De Chabalier F, Decoin M, Bonareck M, Ortega V, Marimoutou C, Dabis F. Hospital-based surveillance and emerging patterns of HIV transmission [letter]. AIDS 1996;10:552-3.
14. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centers. AIDS 1997;11:F101-5.
15. Lot F, Pillonel J, Pinget R, Cazein F, Gouezel P, Laporte A. Diminution brutale du nombre de cas de SIDA: rôle des nouvelles stratégies thérapeutiques [in French]? Bull Epidemiol Hebd 1997; (11):43-5.
16. Mars ME, Loi S, Suzan V, Gallais H. Protease inhibitors lead to a change of infectious diseases unit activity [abstract 203]. Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997.
17. Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census [letter]. N Engl J Med 1997;336: 1531-2.
18. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997;349: 1294.
19. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health 1982;72:1336-43.